The American Institute of Minimally Invasive Surgery (AIMIS), based in Europe, has entered into a strategic collaboration agreement with a large company listed on the Shanghai stock market, CHIMIN Pharmaceuticals, based in China, which also owns quite a few private hospitals.
AIMIS has built a reputation for partnering with the best American and International doctors and surgeons, holding cutting edge technologies to provide unique and exceptional medical treatments with unparalleled outcomes.
Under the terms of this cooperation, AIMIS, in its vision to offer and transfer world class American medical and surgical advancements & technologies in Minimally Invasive Surgery (MIS) and other medical treatments to the world, will provide support to CHIMIN on perspectives of technologies and management for Medical Institutes under CHIMIN.
Overall, AIMIS and CHIMIS have agreed to collaborate on fundamental areas of resource development and international cooperation through areas including: new surgeries in China, new surgeries in Cyprus (where AIMIS operates) as well as Medical Education, Training, Academic, Scientific and Clinical Research.
Innovative and specialized areas that have already been established include Complex Spine Surgery, Stem Cell Technologies and Limb lengthening technologies, the latter for cosmetic applications.